SL
Sol-Gel Technologies Ltd.
SLGL · NASDAQ
$60.74 +2.77% (+$1.64)
1M -26.93%
Market Cap $195.2M
P/E Ratio -
Div. Yield -
ROE 44.05%
Piotroski F-Score Weak
2/9Valuation
25 /100
Expensive P/S 108.74x
P/B 4.06x
P/E N/A
Growth
78 /100
Growing Rev. growth 70.92%
Book val. growth 18.55%
EPS growth N/A
Profitability
22 /100
Weak Gross margin 67.08%
FCF margin 0.00%
Net margin 910.14%
Quality
0 /100
Poor ROIC 35.90%
Asset turnover 0.03x
ROE 44.05%
Debt
100 /100
Low Debt/Equity 0.02x
Current ratio 10.37x
Int. coverage N/A
Stability
19 /100
Unstable Beta 1.13x
Profitable years 0
Rev. volatility 374.12%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SLGL
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Moshe Arkin
Employees
28
Headquarters
Ness Ziona
Upcoming events
19 NOV
Earnings
Upcoming earnings report